Protein aggregation in disease: a role for folding intermediates forming specific multimeric interactions
Open Access
- 1 November 2002
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 110 (9) , 1221-1232
- https://doi.org/10.1172/jci16781
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseasesNature, 2002
- Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformationProceedings of the National Academy of Sciences, 2000
- Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packingThe EMBO Journal, 1999
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Chaperonins can Catalyse the Reversal of Early Aggregation Steps when a Protein MisfoldsJournal of Molecular Biology, 1995
- Characterizing transition states in protein folding: an essential step in the puzzleCurrent Opinion in Structural Biology, 1995
- Chaperonin-mediated protein folding at the surface of groEL through a 'molten globule'-like intermediateNature, 1991
- Quasi‐irreversibility in the unfolding‐refolding transition of phosphoglycerate kinase induced by guanidine hydrochlorideEuropean Journal of Biochemistry, 1987
- Amyloid Deposits and AmyloidosisNew England Journal of Medicine, 1980
- An amyloid protein: The amino-terminal variable fragment of an immunoglobulin light chainBiochemical and Biophysical Research Communications, 1970